Cash fee compensation.

No definition available.

Name:	opgn_CashFeeCompensation
Namespace Prefix:	opgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Class of warrant or right warrants exercised.

+ References

No definition available.

+ Details

Name:	opgn_ClassOfWarrantOrRightWarrantsExercised
Namespace Prefix:	opgn_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Common stock capital shares reserved for future issuance amount.

+ References

No definition available.

+ Details

Name:	opgn_CommonStockCapitalSharesReservedForFutureIssuanceAmount
Namespace Prefix:	opgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Gross proceeds from issuance of common stock.

+ References

No definition available.

+ Details

Name:	opgn_GrossProceedsFromIssuanceOfCommonStock
Namespace Prefix:	opgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Public offering of common stock and warrants, net of issuance costs, shares

+ References

No definition available.

+ Details

Name:	opgn_PublicOfferingOfCommonStockAndWarrantsNetOfIssuanceCostsInShares
Namespace Prefix:	opgn_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Warrants exercisable term.

+ References

No definition available.

+ Details

Name:	opgn_WarrantsExercisableTerm
Namespace Prefix:	opgn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Warrants expiry period.

+ References

No definition available.

+ Details

Name:	opgn_WarrantsExpiryPeriod
Namespace Prefix:	opgn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ConversionOfStockLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of shares issued for each share of convertible preferred stock that is converted.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644

+ Details

Name:	us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Per share conversion price of preferred stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

+ Details

Name:	us-gaap_PreferredStockConvertibleConversionPrice
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.

+ References

+ Details

Name:	us-gaap_PreferredStockParOrStatedValuePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).

+ References

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfWarrants
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The cash inflow associated with the amount received from holders exercising their stock warrants.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromWarrantExercises
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 23
-URI http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

+ Details

Name:	us-gaap_SaleOfStockDescriptionOfTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Per share or per unit amount of equity securities issued.

+ References

No definition available.

+ Details

Name:	us-gaap_SharesIssuedPricePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	dei_LegalEntityAxis=opgn_HealthcareFocusedInstitutionalInvestorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=opgn_OctoberTwoThousandsTwentyOneOfferingPrivatePlacementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=opgn_WarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=opgn_FebruaryTwoThousandsTwentyOneOfferingPrivatePlacementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=opgn_PreFundedWarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=opgn_HolderMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=opgn_ExerciseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=opgn_AllianceGlobalPartnersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=opgn_PurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=opgn_InvestorsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=opgn_HealthcareFocusedUsInstitutionalInvestorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=opgn_TwoThousandTwentyPipeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=opgn_HCWainwrightAndCoLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=opgn_TwoThousandsTwentyAtmOfferingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=opgn_HolderPursuantToCompanyIssuedToHolderSecuritiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Going Concern and Management's Plans (Details) - USD ($)				1 Months Ended		12 Months Ended
	Dec. 08, 2021	Mar. 09, 2021	Feb. 11, 2021	Oct. 18, 2021	Nov. 25, 2020	Dec. 31, 2021	Dec. 31, 2020	Feb. 11, 2020
Conversion of Stock [Line Items]
Preferred Stock, Par or Stated Value Per Share						$ 0.01	$ 0.01
Proceeds from issuance of common stock, net of issuance costs						$ 1,483,833	$ 15,821,922
Healthcare-focused Institutional Investor [Member] \| October 2021 Offering [Member]
Conversion of Stock [Line Items]
Convertible preferred stock	7,500,000			7,500,000		7,500,000
Stock issued during period, shares, new issues	150,000			150,000
Preferred Stock, Par or Stated Value Per Share				$ 100
Conversion preferred stock per share				$ 2.00
Gross proceeds from sale of common stock				$ 15,000,000.0
Proceeds from issuance of common stock, net of issuance costs				$ 13,900,000
Class of warrant or right, exercise price of warrants or rights				$ 2.05
Warrants exercisable period				6 months
Warrants expiry period				5 years
Healthcare-focused Institutional Investor [Member] \| October 2021 Offering [Member] \| Warrants [Member]
Conversion of Stock [Line Items]
Stock issued during period, shares, new issues				7,500,000
Healthcare-focused Institutional Investor [Member] \| February 2021 Offering [Member]
Conversion of Stock [Line Items]
Stock issued during period, shares, new issues			2,784,184
Gross proceeds from sale of common stock			$ 25,000,000.0
Proceeds from issuance of common stock, net of issuance costs			$ 23,500,000
Sale of stock, description of transaction			each pre-funded warrant exercisable for one share of common stock
Healthcare-focused Institutional Investor [Member] \| February 2021 Offering [Member] \| Pre Funded Warrant [Member]
Conversion of Stock [Line Items]
Stock issued during period, shares, new issues			5,549,149			5,549,149
Sale of stock, description of transaction						each pre-funded warrant exercisable for one share of common stock.
Warrants exercised			4,166,666
Holder [Member] \| Exercise Agreement [Member] \| Warrant [Member]
Conversion of Stock [Line Items]
Class of warrant or right, exercise price of warrants or rights		$ 3.56
Warrants expiry period		5 years
Number of each warrant issue to purchase common stock		0.65
New warrants issue against outstanding warrants		3,147,700
Payment to purchase new warrants		$ 255,751
Alliance Global Partners [Member] \| Purchase Agreement [Member] \| Warrant [Member]
Conversion of Stock [Line Items]
Cash fee compensation		$ 200,000
Investor [Member] \| February 2021 Offering [Member]
Conversion of Stock [Line Items]
Offering of common stock and warrants			4,166,666
Shares issued, price per share			$ 3.00
Class of warrant or right, exercise price of warrants or rights			$ 3.55
Warrants exercisable period			6 months
Warrants expiry period			5 years 6 months
Investor [Member] \| February 2021 Offering [Member] \| Pre Funded Warrant [Member]
Conversion of Stock [Line Items]
Shares issued, price per share			$ 2.99
Class of warrant or right, exercise price of warrants or rights			$ 0.01
Healthcare-focused U.S. Institutional Investor [Member] \| 2020 PIPE [Member]
Conversion of Stock [Line Items]
Stock issued during period, shares, new issues					2,245,400
Shares issued, price per share					$ 2.065
Gross proceeds from sale of common stock					$ 10,000,000.0
Proceeds from issuance of common stock, net of issuance costs					$ 9,300,000
Sale of stock, description of transaction					with each pre-funded warrant exercisable for one share of common stock
Class of warrant or right, exercise price of warrants or rights					$ 1.94
Warrants exercisable period					6 months
Warrants exercised		4,842,615			4,842,615
Warrants expiry period					5 years 6 months
New warrants issue against outstanding warrants					2,245,400
Healthcare-focused U.S. Institutional Investor [Member] \| 2020 PIPE [Member] \| Maximum [Member]
Conversion of Stock [Line Items]
Stock issued during period, shares, new issues					2,245,400
Healthcare-focused U.S. Institutional Investor [Member] \| 2020 PIPE [Member] \| Pre Funded Warrant [Member]
Conversion of Stock [Line Items]
Stock issued during period, shares, new issues					2,597,215
Shares issued, price per share					$ 2.055
Sale of stock, description of transaction						each pre-funded warrant exercisable for one share of common stock
Warrants exercised					2,597,215
New warrants issue against outstanding warrants					2,597,215		2,597,215
H.C. Wainwright & Co., LLC [Member] \| Common Stock [Member] \| 2020 ATM Offering [Member]
Conversion of Stock [Line Items]
Stock issued during period, shares, new issues						680,000	7,521,610
Gross proceeds from sale of common stock						$ 1,550,000	$ 16,700,000
Proceeds from issuance of common stock, net of issuance costs						$ 1,480,000	$ 15,800,000
H.C. Wainwright & Co., LLC [Member] \| Common Stock [Member] \| 2020 ATM Offering [Member] \| Maximum [Member]
Conversion of Stock [Line Items]
Common shares available for future issuance amount								$ 22,100,000
Holder pursuant to company issued to Holder securities [Member] \| Warrants [Member]
Conversion of Stock [Line Items]
Proceeds from issuance of warrant		$ 9,650,000